Dielectrophoretic Potential Cages for High-Throughput Cell Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for analyzing cell-drug interactions lack high throughput and biological value, requiring extensive animal testing and being costly and culturally unacceptable, with existing cell matrices being uniform and lacking flexibility for analyzing various cell types and interactions.
Innovation Solution
A method utilizing dielectrophoretic forces to create closed movable potential cages within a testing device, allowing for the identification and separation of unknown entities by affinity with known entities, enabling high-throughput and high-biological-value assays without the need for extensive animal testing, using selectively addressable electrodes and microbeads functionalized with antibodies or ligands.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional cell matrix methods are used, then cell analysis can be performed, but throughput is limited and flexibility for analyzing various cell types is lacking
Solution Approach 1:
The invention segments the cell analysis process into individual well-separated analysis zones within a single chamber, allowing parallel analysis of multiple cells without requiring extensive animal testing. Each zone can independently analyze different cell types or compounds simultaneously
Solution Approach 2:
The testing device is designed with universal applicability to analyze different cell types, compounds, and biological interactions within a single integrated system. The chamber can accommodate various cell matrices and analysis configurations without requiring separate dedicated equipment for each application
2Reliability
If extensive animal testing is conducted, then drug efficacy can be evaluated, but cost increases and cultural acceptability decreases
Solution Approach 1:
The invention performs preliminary high-throughput cell-based screening to evaluate drug efficacy and toxicity before advancing to animal testing. This preliminary action filters out ineffective or toxic compounds early, reducing the number of candidates requiring expensive animal studies while maintaining reliability through rigorous cellular assessment
3Loss of information
If conventional cell-drug interaction analysis is used, then some biological data can be obtained, but the volume of compound required is considerable and throughput is low
Solution Approach 1:
The invention transitions from traditional low-throughput sequential analysis to high-dimensional parallel analysis within a single chamber. Multiple cells are analyzed simultaneously in spatially separated zones, enabling comprehensive biological data collection while using minimal compound volumes delivered through precise microfluidic or droplet-based systems
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables efficient, precise, and cost-effective screening of pharmaceutical compounds by allowing the analysis of thousands of compounds in parallel, reducing the need for animal testing, and providing detailed biological activity data at the single-cell level with minimal reagents and low reaction volumes.
Implementation Method 1
selectively creating closed movable potential cages by means of dielectrophoretic force generated by the opposed electrodes and trapping at least a part of the entities within the movable cages
Data Source
AI summary
First entities consisting in cells or microorganisms (BIO) and second entities consisting in compounds or compound units, carried typically by microbeads (BEAD), are trapped selectively within closed movable potential cages (S1) by means of dielectrophoretic force generated by mutually opposed electrodes (M1, M2). The cages are set in relative motion so as to bring about the interaction of selected first and second entities, causing the cages containing them to fuse, whereupon results are obtained preferably by reinstating the original cages and/or observing previously empty adjacent cages. The procedure takes place in a device (DE) with two separate chambers (F, FL) connected one to the other by way of a narrow passage (D) and finished with respective selectively controllable inlets and outlets (I1, I2; O1, O2) through which a liquid or semi-liquid buffer (L) can be pumped in or out.